UPDATE: FDA Clarifies Abbott Alinity Kits’ Recall Is for Software, Details Fix
The FDA has updated the Abbott Alinity Kits’ recall is for a software issue, which can be corrected with an update.
Read MorePosted by Chris Wolski | Sep 20, 2021 | Immunoassay Reagents & test Kits |
The FDA has updated the Abbott Alinity Kits’ recall is for a software issue, which can be corrected with an update.
Read MorePosted by Toni Mitchell | Sep 20, 2021 | Biochemicals & Chemical Reagents, Covid 19 |
Thomas Scientific has partnered with Truckee Applied Genomics (TAG) to distribute its patient sample transport reagents.
Read MorePosted by Chris Wolski | Sep 17, 2021 | Compliance |
Certain temporary deviations in FDA policy in response to the COVID-19 pandemic may offer a blueprint for regulatory oversight of LDTs.
Read MorePosted by Toni Mitchell | Sep 17, 2021 | Covid 19, Rapid Assays |
Rockefeller University’s “DRUL” saliva test performs as well as, if not better, than FDA-authorized nasal and oral swab tests.
Read MorePosted by Chris Wolski | Sep 16, 2021 | Disease States |
Cairn Diagnostics has announced that the U.S. FDA has expanded the approval of the company’s 13C-Spirulina GEBT to now include “at home” administration.
Read More